Last updated on February 2018

Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Women With Primary Ovarian Insufficiency (POI)


Brief description of study

There is a high incidence of women suffering from Primary Ovarian Insufficiency (POI). One of the most common treatments for POI is hormone replacement therapy (HRT), but HRT doesn't work well, and it has been shown to increase the risk of blood clots in the veins, ovarian cancer, and breast cancer. The ability of MSCs to differentiate into oocyte-like cells has been previously documented. Herein the purpose of this work is to evaluate the therapeutic potential of cell therapy in women suffering from POI.

Clinical Study Identifier: NCT03033277

Contact Investigators or Research Sites near you

Start Over

Jianqiao Liu, Doctor

Institute of Zoology, Chinese Academy of Sciences.
Beijing, China
  Connect »